RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map ACCESSWIRE 11 May 2021, 20:05 GMT+10 Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ('RepliCel' or the 'Company') is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ('UBC') that enables the second stage of its cell marker research. The project is being co-led by RepliCel's Dr. Kevin McElwee and UBC's Professor Youwen Zhou.